In research, we deal with all aspects of hormonal and metabolic diseases, both in the clinical and in the preclinical area. The aim of our research is to improve the treatment and care of affected patients. This is ensured by the long-standing tradition of top international research in our department as well as through cooperation with partners around the world and close links with university teaching.
Endocrinology and metabolism are cutting-edge research areas with an annual volume of over 300,000 publications worldwide.
Almost every member of the population - from newborns to old age - is affected in one form or another by an endocrinological or metabolic issue. Many “widespread diseases” are also largely endocrine-metabolically conditioned, such as hypertension (hypertension), diabetes mellitus (diabetes) or osteoporosis (bone loss).
For this reason, our department has set up its own endocrinology laboratory platform.
Our division has set itself the task of doing research on the following topics up to date:
Diabetes mellitus (types 1 and 2 as well as all other types), diabetic foot syndrome, diabetes technology, diabetes mellitus during pregnancy and the desire to have children, cardiovascular diabetology, lipid metabolism disorders, thyroid disorders, disorders of the pituitary gland, disorders of the adrenal gland, disorders of the male calcium metabolism, endocrine hypertension, disorders of the male metabolism and female gonads, desire to have children, bone metabolism, bone structure analysis and osteoporosis.
People who have type 1 diabetes tend to have another autoimmune disease more often. Patients with type 1 diabetes are about three times more likely to develop multiple sclerosis. Patients with type 1 diabetes and lupus erythematosus also develop kidney complications more often. For this reason, the JDRF, the LRA and the Multiple Sclerosis Society have come together to promote research into an understanding of autoimmune diseases in a focused manner and to investigate more specific insights into similarities and differences in the processes in the immune system that control these disease processes.
Thomas Pieber and his multi-professional team are part of this innovative international research project.
